Financial statements Innovabion
Balance sheet data of INNOVABION
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 1 214 448,23 | 2 645 220,13 | 18 058 282,49 | 14 009 872,14 | 15 792 004,66 | 16 666 924,60 |
| A. Fixed assets | 40 381,89 | 949 558,21 | 6 189 137,56 | 7 743 018,72 | 7 446 949,31 | 7 935 078,60 |
| B. Current assets | 1 174 066,34 | 1 695 661,92 | 11 869 144,93 | 6 266 853,42 | 8 345 055,35 | 8 731 846,00 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | - |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | - |
| Total liabilities | 1 214 448,23 | 2 645 220,13 | 18 058 282,49 | 14 009 872,14 | 15 792 004,66 | 16 666 924,60 |
| A. Equity | 84 402,03 | -411 571,23 | 2 862 016,91 | 4 489 727,94 | 5 467 055,44 | 6 070 355,44 |
| B. Liabilities and provisions for liabilities | 1 130 046,20 | 3 056 791,36 | 15 196 265,58 | 9 520 144,20 | 10 324 949,22 | 10 596 569,16 |
| I. Long-term liabilities | - | - | 3 122 458,09 | 4 062 718,92 | 4 323 468,05 | 2 954 908,29 |
| II. Short-term liabilities | - | - | 10 252 504,86 | 4 518 511,82 | 5 462 567,71 | 7 102 747,41 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.